Keya Wakins Senior Vice President, Catalyst Oncology Catalyst Clinical Research Keya brings 25 years of experience in drug development with both biopharma and clinical service providers. As Senior Vice President of Catalyst Oncology, Keya is responsible for the execution of the Oncology CRO Operations. Keya has built and provided oversight of multidisciplinary teams across clinical development operations inclusive of clinical operations, data sciences and trial support services previously. She also served as an executive in both operational and commercial roles and has been involved in several complex, global trials in various therapeutic areas and phases with a concentration on oncology and hematology programs. Keya prides herself on building and managing high-functioning teams that deliver excellence while ultimately bringing meaningful therapies to patients in need. Keya earned her degree from Temple University, Philadelphia, Pennsylvania, and also maintains her certification as a Project Management Professional.